This year’s list of the world’s most Highly Cited Researchers include WSU experts in business, chemistry, Earth science, engineering, food, and medicine.
Velocity Clinical Research, Inc : Velocity aggressively expands MASH/MASLD capabilities with latest site acquisitions finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Velocity MASH principal investigators from left to right: Dr Kowdley, Dr Gunn and Dr Kuchta Velocity MASH principal investigators from left to right: Dr Kowdley, Dr Gunn and Dr Kuchta • Add two KOLs: Dr Kris Kowdley and Dr Nadege Gunn • Builds on existing MASH/MASLD capabilities at 23 sites globally DURHAM N.C., Oct. 25, 2023 (GLOBE NEWSWIRE) Velocity Clinical Research (“Velocity”), the leading multi-specialty clinical sites business, announced it has acquired Impact Research Institute (Waco,
A study to evaluate the effect of seladelparm, a small molecule treatment by CymaBay Therapeutics, Inc. on patients with cirrhosis was announced this month (September 21).